Improving continuity of patient care across sectors: study protocol of the process evaluation of a quasi-experimental multi-centre study regarding an admission and discharge model in Germany (VESPEERA).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
12 11 2019
Historique:
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 28 10 2020
Statut: epublish

Résumé

Hospital stays are critical events as they often disrupt continuity of care. This process evaluation aims to describe and explore the implementation of the VESPEERA programme (Improving continuity of patient care across sectors: An admission and discharge model in general practices and hospitals, V The process evaluation is linked to the VESPEERA outcomes evaluation, which has a quasi-experimental multi-centre design with four study arms and is conducted in hospitals and general practices in Germany. The VESPEERA programme comprises several components: an assessment before admission, an admission letter, a telephonic discharge conversation between hospital and general practice before discharge, discharge information for patients, structured planning of follow-up care after discharge in the general practice and a telephone monitoring for patients with a risk of rehospitalisation. The process evaluation has a mixed-methods design, incorporating interviews (patients, both care providers who do and do not participate in the VESPEERA programme, total n=75), questionnaires (patients and care providers who participate in the VESPEERA programme, total n=475), implementation plans of hospitals, data documented in general practices, claims-based data and hospital process data. Data analysis is descriptive and explorative. Qualitative data will be transcribed and analysed using framework analysis based on the Consolidated Framework for Implementation Research. Associations between the outcomes of the program and measures in the process evaluation will be explored in regression models. Ethics approval has been obtained by the ethics committee of the Medical Faculty Heidelberg prior to the start of the study (S-352/2018). Results will be disseminated through a final report to the funding agency, articles in peer-reviewed journals and conferences. http://www.drks.de/DRKS00015183. The study protocol on hand is the protocol V.1.1 from 18 June 2018. Recruitment for interviews started on 3 September 2018 and will approximately be completed by the end of May 2019.

Identifiants

pubmed: 31722944
pii: bmjopen-2019-031245
doi: 10.1136/bmjopen-2019-031245
pmc: PMC6858220
doi:

Banques de données

DRKS
['DRKS00015183']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e031245

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JS holds stocks of the aQua-Institut.

Références

Ann Intern Med. 2012 Sep 18;157(6):417-28
pubmed: 22986379
BMJ Open. 2014 May 23;4(5):e004746
pubmed: 24860000
JAMA Intern Med. 2016 Apr;176(4):496-502
pubmed: 26954698
BMJ. 2006 Feb 18;332(7538):413-6
pubmed: 16484270
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD009255
pubmed: 21735443
BMJ. 1999 Mar 13;318(7185):711-5
pubmed: 10074018
Implement Sci. 2014 Jan 17;9:14
pubmed: 24438584
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Fam Pract. 2014 Oct;31(5):502-16
pubmed: 25216664
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
BMC Health Serv Res. 2019 Mar 29;19(1):206
pubmed: 30925879
BMC Health Serv Res. 2014 Nov 25;14:590
pubmed: 25421916
Br J Gen Pract. 2009 Apr;59(561):e134-41
pubmed: 19341548
Ann Intern Med. 2003 Feb 4;138(3):161-7
pubmed: 12558354
Ann Intern Med. 2016 Mar 1;164(5):323-30
pubmed: 26833209
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318

Auteurs

Johanna Forstner (J)

Department of General Practice and Health Services Research, Heidelberg University, Heidelberg, Germany johanna.forstner@med.uni-heidelberg.de.

Aline Kunz (A)

Department of General Practice and Health Services Research, Heidelberg University, Heidelberg, Germany.

Cornelia Straßner (C)

Department of General Practice and Health Services Research, Heidelberg University, Heidelberg, Germany.

Lorenz Uhlmann (L)

Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.

Stephanie Kuemmel (S)

aQua-Institut GmbH, Göttingen, Germany.

Joachim Szecsenyi (J)

Department of General Practice and Health Services Research, Heidelberg University, Heidelberg, Germany.

Michel Wensing (M)

Department of General Practice and Health Services Research, Heidelberg University, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH